Merck (MRK) Tops Q1 EPS by 8c; updates guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $144.30 --0%
Revenue Growth %: +0.2%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +0.2%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
(Updated - April 24, 2025 6:43 AM EDT)
Merck (NYSE: MRK) reported Q1 EPS of $2.22, $0.08 better than the analyst estimate of $2.14. Revenue for the quarter came in at $15.53 billion versus the consensus estimate of $15.33 billion.
GUIDANCE:
Merck sees FY2025 EPS of $8.82-$8.97, versus the consensus of $8.94. Merck sees FY2025 revenue of $64.1-65.6 billion, versus the consensus of $65.01 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clear Street Starts Bitzero (AIBZ) at Buy
- H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
- H.C. Wainwright Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
